These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC. Tsume Y, Mudie DM, Langguth P, Amidon GE, Amidon GL. Eur J Pharm Sci; 2014 Jun 16; 57():152-63. PubMed ID: 24486482 [Abstract] [Full Text] [Related]
5. Oral absorption of poorly water-soluble drugs: computer simulation of fraction absorbed in humans from a miniscale dissolution test. Takano R, Sugano K, Higashida A, Hayashi Y, Machida M, Aso Y, Yamashita S. Pharm Res; 2006 Jun 16; 23(6):1144-56. PubMed ID: 16715363 [Abstract] [Full Text] [Related]
8. Is the full potential of the biopharmaceutics classification system reached? Bergström CA, Andersson SB, Fagerberg JH, Ragnarsson G, Lindahl A. Eur J Pharm Sci; 2014 Jun 16; 57():224-31. PubMed ID: 24075971 [Abstract] [Full Text] [Related]
10. PAMPA--a drug absorption in vitro model. 5. Unstirred water layer in iso-pH mapping assays and pKa(flux)--optimized design (pOD-PAMPA). Ruell JA, Tsinman KL, Avdeef A. Eur J Pharm Sci; 2003 Dec 16; 20(4-5):393-402. PubMed ID: 14659483 [Abstract] [Full Text] [Related]
11. Understanding peroral absorption: regulatory aspects and contemporary approaches to tackling solubility and permeability hurdles. B Shekhawat P, B Pokharkar V. Acta Pharm Sin B; 2017 May 16; 7(3):260-280. PubMed ID: 28540164 [Abstract] [Full Text] [Related]
12. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety. Meanwell NA. Chem Res Toxicol; 2011 Sep 19; 24(9):1420-56. PubMed ID: 21790149 [Abstract] [Full Text] [Related]
13. A modified physiological BCS for prediction of intestinal absorption in drug discovery. Zaki NM, Artursson P, Bergström CA. Mol Pharm; 2010 Oct 04; 7(5):1478-87. PubMed ID: 20734997 [Abstract] [Full Text] [Related]
14. Prediction of solubility and permeability class membership: provisional BCS classification of the world's top oral drugs. Dahan A, Miller JM, Amidon GL. AAPS J; 2009 Dec 04; 11(4):740-6. PubMed ID: 19876745 [Abstract] [Full Text] [Related]
15. Predicting the oral absorption of a poorly soluble, poorly permeable weak base using biorelevant dissolution and transfer model tests coupled with a physiologically based pharmacokinetic model. Wagner C, Jantratid E, Kesisoglou F, Vertzoni M, Reppas C, B Dressman J. Eur J Pharm Biopharm; 2012 Sep 04; 82(1):127-38. PubMed ID: 22652546 [Abstract] [Full Text] [Related]
16. In vitro solubility, dissolution and permeability studies combined with semi-mechanistic modeling to investigate the intestinal absorption of desvenlafaxine from an immediate- and extended release formulation. Franek F, Jarlfors A, Larsen F, Holm P, Steffansen B. Eur J Pharm Sci; 2015 Sep 18; 77():303-13. PubMed ID: 26091569 [Abstract] [Full Text] [Related]